MCID: ORL005
MIFTS: 51

Oral Candidiasis

Categories: Oral diseases, Infectious diseases

Aliases & Classifications for Oral Candidiasis

MalaCards integrated aliases for Oral Candidiasis:

Name: Oral Candidiasis 12 51 14 69
Thrush 12 72 3
Candidiasis of Mouth 12
Candidiasis, Oral 41
Oral Moniliasis 12
Equine Thrush 69
Thrush, Oral 12
Candidiasis 69
Oral Thrush 59

Classifications:



External Ids:

Disease Ontology 12 DOID:14262
ICD10 32 B37.0 B37.9
ICD9CM 34 112.0
MeSH 41 D002180
NCIt 46 C28137

Summaries for Oral Candidiasis

PubMed Health : 59
About oral thrush: Oral thrush is a condition that can be difficult to recognize at first. It is rarely dangerous and not necessarily painful, but can be very unpleasant and greatly affect your quality of life. Oral thrush is caused by types of yeast fungus called Candida that live in the mucous membranes lining your mouth. Its medical name “oral candidiasis” is taken from this fungus. Oral thrush is most often caused by a type of Candida fungus called Candida albicans.Most people have small amounts of Candida on the mucous linings of their mouth without it causing any noticeable problems. But given the right conditions, the fungus can start reproducing very quickly. This often affects people who have serious diseases, and it can also be a side effect of certain types of treatment.

MalaCards based summary : Oral Candidiasis, also known as thrush, is related to candidiasis and immunodeficiency 32b, and has symptoms including oral manifestations An important gene associated with Oral Candidiasis is DEFB4A (Defensin Beta 4A), and among its related pathways/superpathways are Innate Immune System and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Fluconazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include tongue, skin and kidney.

Disease Ontology : 12 A candidiasis that involves fungal infection of the mucous membrane of the mouth by Candida species, which is characterized by thick white or cream-colored deposits on inflamed mucosal membranes.

CDC : 3 Candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Candida normally lives in the digestive tract and on skin without causing any problems.1 Sometimes, Candida can multiply and cause an infection if the environment inside the mouth, throat, or esophagus changes in a way that encourages fungal growth.

Wikipedia : 72 Candidiasis is a fungal infection due to any type of Candida (a type of yeast). When it affects the... more...

Related Diseases for Oral Candidiasis

Diseases related to Oral Candidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 117)
# Related Disease Score Top Affiliating Genes
1 candidiasis 31.4 DEFB4A HTN3 SKAP2
2 immunodeficiency 32b 11.1
3 severe combined immunodeficiency 11.0
4 jak3-deficient severe combined immunodeficiency 11.0
5 reticular dysgenesis 11.0
6 median rhomboid glossitis 11.0
7 corneal abscess 10.4 DEFB1 DEFB4A
8 osteonecrosis of the jaw 10.4 DEFB1 DEFB4A
9 microsporidiosis 10.4 DEFA1 DEFB4A
10 dermatophytosis 10.4 DEFB4A LTF
11 periodontitis, aggressive, 1 10.3 IL1A LTF
12 vaginal disease 10.3 CXCL8 DEFB4A
13 cholesteatoma of middle ear 10.3 DEFB4A IL1A
14 felty syndrome 10.3 CXCL8 LTF
15 giant papillary conjunctivitis 10.3 CXCL8 LTF
16 sinusitis 10.3 CXCL8 DEFB4A
17 haemophilus influenzae 10.3 CXCL8 LTF
18 leukoregulin 10.2 CXCL8 IL1A
19 scabies 10.2 CXCL8 IL1A
20 multidrug-resistant tuberculosis 10.2 DEFA1 IL1A
21 septic arthritis 10.2 CXCL8 DEFB4A
22 dysentery 10.2 IL1A LTF
23 leukoplakia 10.2
24 candida glabrata 10.2 HTN3 SKAP2
25 neurofibromatosis, type ii 10.2 DEFB1 DEFB4A IL1A
26 meningococcemia 10.2 IL1A IL1RN
27 cholesteatoma 10.2 DEFB1 DEFB4A IL1A
28 necrotizing fasciitis 10.1 CXCL8 IL1RN
29 keratoconjunctivitis sicca 10.1 IL1A LTF
30 opportunistic mycosis 10.1 SKAP2 ST5
31 bullous keratopathy 10.1 CXCL8 IL1A
32 mucositis 10.1
33 vulvovaginal candidiasis 10.1 DEFB1 DEFB4A IL1RN
34 aseptic meningitis 10.1 CXCL8 IL1RN
35 sebaceous gland disease 10.1 CXCL8 DEFB4A IL1A
36 bacterial vaginosis 10.1 CXCL8 DEFB4A IL1A
37 root resorption 10.1 IL1A IL1RN
38 tibial neuropathy 10.1 B2M SKAP2
39 tarsal tunnel syndrome 10.1 B2M SKAP2
40 oral hairy leukoplakia 10.0
41 tonsillitis 10.0 CXCL8 DEFB1 IL1A
42 periodontitis 10.0 CXCL8 DEFB1 IL1A
43 bronchopulmonary dysplasia 10.0 CXCL8 IL1RN
44 leukemia 10.0
45 acquired immunodeficiency syndrome 10.0
46 idiopathic neutropenia 9.9 IL1A IL1RN
47 pouchitis 9.9 CXCL8 IL1RN LTF
48 diabetes mellitus 9.9
49 post-transplant lymphoproliferative disease 9.9 B2M IL1A
50 silicosis 9.9 CXCL8 IL1A IL1RN

Comorbidity relations with Oral Candidiasis via Phenotypic Disease Network (PDN): (show all 37)


Acquired Thrombocytopenia Active Peptic Ulcer Disease
Acute Cystitis Acute Kidney Failure
Alzheimer Disease Anxiety
Bronchitis Bronchopneumonia
Chronic Myocardial Ischemia Chronic Pulmonary Heart Disease
Conn's Syndrome Decubitus Ulcer
Deficiency Anemia Dysthymic Disorder
Esophageal Candidiasis Esophagitis
Familial Atrial Fibrillation Glossitis
Heart Disease Hypertension, Essential
Hypothyroidism Iron Deficiency Anemia
Ischemic Heart Disease Neutropenia
Osteoporosis Paralytic Ileus
Peripheral Vascular Disease Pharyngitis
Pneumocystosis Postinflammatory Pulmonary Fibrosis
Protein-Energy Malnutrition Respiratory Failure
Rheumatoid Arthritis Schizophreniform Disorder
Status Asthmaticus Swallowing Disorders
Vulvovaginal Candidiasis

Graphical network of the top 20 diseases related to Oral Candidiasis:



Diseases related to Oral Candidiasis

Symptoms & Phenotypes for Oral Candidiasis

UMLS symptoms related to Oral Candidiasis:


oral manifestations

Drugs & Therapeutics for Oral Candidiasis

PubMedHealth treatment related to Oral Candidiasis: 59

Oral thrush can be treated with antimycotics. These are available as drugs that produce either a topical (local) or a systemic (throughout the whole body) effect. Medication that acts in both ways is also an option. The type of medication that is best suited for someone with a weakened immune system will depend on their individual situation.

Drugs for Oral Candidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2 86386-73-4 3365
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 22916-47-8 4189
3 Adrenergic Agents Phase 4,Phase 3,Phase 2
4 Adrenergic Agonists Phase 4,Phase 3,Phase 2
5 Adrenergic beta-2 Receptor Agonists Phase 4,Phase 3,Phase 2
6 Adrenergic beta-Agonists Phase 4,Phase 3,Phase 2
7 Anti-Allergic Agents Phase 4,Phase 3,Phase 2
8 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2
9 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
10 Autonomic Agents Phase 4,Phase 3,Phase 2
11 Bronchodilator Agents Phase 4,Phase 3,Phase 2
12 Dermatologic Agents Phase 4,Phase 3,Phase 2
13
Fluticasone Phase 4,Phase 3,Phase 2 80474-14-2, 90566-53-3 22833648 62924
14 Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Phase 4,Phase 3
15 glucocorticoids Phase 4,Phase 3
16 Hormone Antagonists Phase 4,Phase 3,Phase 2
17 Hormones Phase 4,Phase 3,Phase 2
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
19 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
20 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
21 Respiratory System Agents Phase 4,Phase 3,Phase 2
22
Salmeterol xinafoate Phase 4,Phase 3 94749-08-3 56801
23 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
24 Antibiotics, Antitubercular Phase 4,Phase 3
25 Antifungal Agents Phase 4,Phase 3,Phase 2
26 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2
28 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2
29 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
30 Antitubercular Agents Phase 4,Phase 3
31
Posaconazole Approved, Investigational, Vet_approved Phase 3 171228-49-2 147912
32
Gentian Violet Approved Phase 3 7438-46-2, 14426-25-6 3468
33
Ketoconazole Approved, Investigational Phase 3 65277-42-1 3823 47576
34
Nystatin Approved, Vet_approved Phase 3,Phase 2 1400-61-9 11953884
35
Pilocarpine Approved, Investigational Phase 3 92-13-7, 54-71-7 5910
36
Procaterol Approved, Investigational Phase 3 72332-33-3 688561
37
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
38
Budesonide Approved Phase 3 51333-22-3 5281004 63006
39
Sulfamethoxazole Approved Phase 3 723-46-6 5329
40
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
41
Everolimus Approved Phase 3 159351-69-6 6442177
42
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
43
Mycophenolic acid Approved Phase 3 24280-93-1 446541
44
Sirolimus Approved, Investigational Phase 3 53123-88-9 46835353 6436030 5284616
45
Tacrolimus Approved, Investigational Phase 3 104987-11-3 445643 439492
46
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
47
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
48 Analgesics Phase 3
49 Antiparasitic Agents Phase 3,Phase 2
50 Antiprotozoal Agents Phase 3,Phase 2

Interventional clinical trials:

(show all 49)

# Name Status NCT ID Phase Drugs
1 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
2 Fluconazole Prophylaxis of Thrush in AIDS Completed NCT00001542 Phase 4 fluconazole
3 A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Completed NCT00000951 Phase 4 Fluconazole
4 Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania Completed NCT00553137 Phase 4 fluconazole;fluconazole
5 RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section Withdrawn NCT02009098 Phase 4 Cefuroxime
6 Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Completed NCT00002446 Phase 3 Posaconazole;Fluconazole
7 A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Completed NCT00128323 Phase 3 Gentian violet 1% solution;Gentian violet 0.00165% solution;Nystatin solution
8 Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic Completed NCT02818803 Phase 3 Miconazole
9 Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis Completed NCT01427738 Phase 3 Gentian Violet;Nystatin oral suspension
10 Effect of Probiotic Lozenge on Gingivitis and Periodontitis Completed NCT02203812 Phase 3 Probiotic Arm;Placebo Arm
11 Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients Completed NCT00168181 Phase 3 Salagen
12 A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Completed NCT00001812 Phase 3 Nystatin
13 Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma Completed NCT02175771 Phase 3 Fp MDPI;FS MDPI;FLOVENT HFA;ADVAIR DISKUS;albuterol/salbutamol HFA
14 Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study Completed NCT01018186 Phase 3 Fluticasone Furoate/GW642444;Fluticasone propionate
15 Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy Completed NCT00152867 Phase 3 Dexamethasone
16 Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy Completed NCT02181335 Phase 3 Respimat® Budesonide low dose;Respimat® Budesonide high dose;Turbohaler® Budesonide;Placebo
17 Prophylactic Antibiotics in Measles Completed NCT00168532 Phase 3 Sulfamethoxazole-Trimethoprim
18 Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score Not yet recruiting NCT03386539 Phase 3 Everolimus;Tacrolimus;Mycophenolate Mofetil
19 Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis Completed NCT00659971 Phase 2 PAC113
20 A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole Completed NCT00001065 Phase 2 Amphotericin B
21 Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches Completed NCT00835029 Phase 2 Clotrimazole varnish;Clotrimazole troches
22 Quaternary Ammonium Methacryloxy Silicate-containing Acrylic Resin Completed NCT02525458 Phase 2
23 Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis Completed NCT01926028 Phase 1, Phase 2
24 A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications Completed NCT01576718 Phase 2 Fp MDPI;Flovent Diskus;albuterol/salbutamol
25 Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure Completed NCT00168116 Phase 2
26 CelAgace™ OraRinse Solution for Treatment of Candidiasis Enrolling by invitation NCT03250923 Phase 1, Phase 2 silver citrate complex and acemannan
27 Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole Terminated NCT00005920 Phase 2 L-743,872
28 The Effect of Palatal Brushing on Denture Stomatitis Completed NCT01643876 Phase 1
29 Modified Directly Observed Antiretroviral Therapy Unknown status NCT01985269
30 Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy Completed NCT00768794
31 Novel Rinse to Treat in Oral Candidiasis in Cancer Patients Completed NCT00612963 Frio Oral Rinse
32 Oral Candida in Infants and Dietary Type Completed NCT01438983
33 The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection Completed NCT00001448
34 Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC Completed NCT00002057 Nystatin
35 Effect of Probiotic Bacteria on Oral Candida in Frail Elderly Completed NCT02391532
36 A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes Completed NCT00002293 Nystatin
37 The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients Completed NCT00002431 Chlorhexidine gluconate
38 Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment Completed NCT00002394 Terbinafine hydrochloride
39 Experimental Denture Pastes Completed NCT01237795
40 Efficacy of a Propolis-based Denture Cleanser Completed NCT01237782 Denture soaking solution;Saline solution
41 Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC) Completed NCT00002043 Dapsone
42 Do Traditional or Flavored Tongue Depressors Make for Easier Posterior Oropharynx Exams in Pediatric Patients Completed NCT03095183
43 Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals Completed NCT00865826
44 Interventional Study Targeting Oral Infections in Patients With Chronic Kidney Disease Completed NCT02357199
45 Qvar Versus Clenil, a General Practice Research Database Study Completed NCT01400217 extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler;standard particle particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler
46 Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management Completed NCT01242098 Fixed dose combination salmeterol / fluticasone;Fixed-dose combination beclometasone dipropionate / formoterol
47 The Effectiveness of Palatal Brushing on Denture Stomatitis Recruiting NCT02686632
48 Photobiomodulation in Oral Lichen Planus Not yet recruiting NCT03320460 Propionate clobetasol gel 0.05%
49 Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility Terminated NCT00692783

Search NIH Clinical Center for Oral Candidiasis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: candidiasis, oral

Genetic Tests for Oral Candidiasis

Anatomical Context for Oral Candidiasis

MalaCards organs/tissues related to Oral Candidiasis:

38
Tongue, Skin, Kidney, Salivary Gland, Heart, Colon, Neutrophil

Publications for Oral Candidiasis

Articles related to Oral Candidiasis:

(show top 50) (show all 420)
# Title Authors Year
1
Prevalence and association of oral candidiasis with dysphagia in individuals with acquired brain injury. ( 29182379 )
2018
2
Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis. ( 29380647 )
2018
3
A meta-analysis of randomized trials assessing the effects of probiotic preparations on oral candidiasis in the elderly. ( 28783552 )
2017
4
Quantity of Candida Colonies in Saliva: a8"A Diagnostic Evaluation for Oral Candidiasis. ( 28232964 )
2017
5
TNF as marker of oral candidiasis, HSV infection, and mucositis onset during chemotherapy in leukemia patients. ( 28403570 )
2017
6
Volatile organic compounds in the breath of oral candidiasis patients: a pilot study. ( 28601915 )
2017
7
Oral health: Asthma and oral candidiasis. ( 29123274 )
2017
8
Oral candidiasis: A retrospective study of 276 Brazilian patients. ( 29391707 )
2017
9
Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis. ( 28977047 )
2017
10
Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. ( 28748027 )
2017
11
Inherited IL-12RI^1 Deficiency in a Child With BCG Adenitis and Oral Candidiasis: A Case Report. ( 29025965 )
2017
12
Assessment of Effectiveness of Fluconazole and Clotrimazole in Treating Oral Candidiasis Patients: A Comparative Study. ( 28462176 )
2017
13
The potential management of oral candidiasis using anti-biofilm therapies. ( 28818264 )
2017
14
Development and Evaluation of Buccal Films Based on Chitosan for the Potential Treatment of Oral Candidiasis. ( 28108973 )
2017
15
Treatment and Prevention of Oral Candidiasis in Elderly Patients. ( 28566666 )
2017
16
FACTORS RELATED TO ORAL CANDIDIASIS IN ELDERLY USERS AND NON-USERS OF REMOVABLE DENTAL PROSTHESES. ( 27007560 )
2016
17
Treatment of Oral Candidiasis Using PhotodithazineAr- Mediated Photodynamic Therapy In Vivo. ( 27253525 )
2016
18
Fluorescence of Candida in diagnosis of oral candidiasis. ( 28169259 )
2016
19
Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. ( 26932256 )
2016
20
Quantification of oral palatine Langerhans cells in HIV/AIDS associated oral Kaposi sarcoma with and without oral candidiasis. ( 27461637 )
2016
21
Oral candidiasis following steroid therapy for oral lichen planus. ( 26599999 )
2016
22
Elucidating the Role of Hyposalivation and Autoimmunity in Oral Candidiasis. ( 27998016 )
2016
23
Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. ( 27042008 )
2016
24
Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern. ( 27403171 )
2016
25
Plasma Levels of IFN-I^, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis. ( 27127595 )
2016
26
Molecular analysis of fungal populations in patients with oral candidiasis using next-generation sequencing. ( 27305838 )
2016
27
Topical Antimycotics for Oral Candidiasis in Warfarin Users. ( 27901310 )
2016
28
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. ( 27358561 )
2016
29
Elimination of oral candidiasis may increase stimulated whole salivary flow rate. ( 27497081 )
2016
30
Development and evaluation of N-naphthyl-N,O-succinyl chitosan micelles containing clotrimazole for oral candidiasis treatment. ( 27050629 )
2016
31
The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial. ( 27977721 )
2016
32
Oral candidiasis. ( 27343964 )
2016
33
Prevention of Oral Candidiasis After Free Flap Surgery: Role of 3% Sodium Bicarbonate Saline in Oral Care. ( 27669373 )
2016
34
Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. ( 26456226 )
2015
35
Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease. ( 25422264 )
2015
36
Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis. ( 26256338 )
2015
37
Innovation of natural essential oil-loaded Orabase for local treatment of oral candidiasis. ( 26170621 )
2015
38
Anti-Candida activity of aroma candy and its protective activity against murine oral candidiasis. ( 25855024 )
2015
39
Does scientific evidence for the use of natural products in the treatment of oral candidiasis exist? A systematic review. ( 25883668 )
2015
40
Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study. ( 26481235 )
2015
41
Direct Microscopy: A Useful Tool to Diagnose Oral Candidiasis in Children and Adolescents. ( 26329143 )
2015
42
C/EBPI^ Promotes Immunity to Oral Candidiasis through Regulation of I^-Defensins. ( 26317211 )
2015
43
Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities. ( 25819801 )
2015
44
Novel aggregation properties of Candida albicans secreted aspartyl proteinase Sap6 mediates virulence in oral candidiasis. ( 25870228 )
2015
45
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. ( 26148537 )
2015
46
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. ( 26416861 )
2015
47
Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels. ( 25682023 )
2015
48
Human immunodeficiency virus induced oral candidiasis. ( 26538978 )
2015
49
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis. ( 26596951 )
2015
50
Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis. ( 26719641 )
2015

Variations for Oral Candidiasis

Expression for Oral Candidiasis

Search GEO for disease gene expression data for Oral Candidiasis.

Pathways for Oral Candidiasis

GO Terms for Oral Candidiasis

Cellular components related to Oral Candidiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 B2M CXCL8 DEFA1 DEFB1 DEFB4A IL1A
2 Golgi lumen GO:0005796 9.33 DEFA1 DEFB1 DEFB4A
3 extracellular region GO:0005576 9.28 B2M CXCL8 DEFA1 DEFB1 DEFB4A HTN3

Biological processes related to Oral Candidiasis according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 chemotaxis GO:0006935 9.76 CXCL8 DEFA1 DEFB1 DEFB4A
2 defense response GO:0006952 9.71 CXCL8 DEFA1 DEFB1 DEFB4A
3 defense response to Gram-positive bacterium GO:0050830 9.69 DEFA1 DEFB1 DEFB4A
4 defense response to Gram-negative bacterium GO:0050829 9.67 DEFB1 DEFB4A LTF
5 defense response to bacterium GO:0042742 9.63 DEFA1 DEFB1 DEFB4A HTN3 IRF8 LTF
6 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.62 DEFA1 DEFB1 DEFB4A LTF
7 antibacterial humoral response GO:0019731 9.61 DEFA1 DEFB1 LTF
8 iron ion homeostasis GO:0055072 9.58 B2M LTF
9 retina homeostasis GO:0001895 9.57 B2M LTF
10 response to bacterium GO:0009617 9.56 DEFB1 IRF8
11 killing of cells of other organism GO:0031640 9.56 DEFA1 DEFB4A HTN3 LTF
12 defense response to fungus GO:0050832 9.55 DEFA1 HTN3
13 defense response to protozoan GO:0042832 9.54 DEFA1 IRF8
14 innate immune response in mucosa GO:0002227 9.54 DEFA1 DEFB1 LTF
15 response to molecule of bacterial origin GO:0002237 9.52 B2M CXCL8
16 fever generation GO:0001660 9.48 IL1A IL1RN
17 antimicrobial humoral response GO:0019730 9.35 DEFA1 DEFB1 DEFB4A HTN3 LTF
18 immune response GO:0006955 9.23 B2M CXCL8 DEFA1 DEFB1 DEFB4A IL1A

Molecular functions related to Oral Candidiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.33 CXCL8 IL1A IL1RN
2 interleukin-1 receptor binding GO:0005149 8.96 IL1A IL1RN
3 CCR6 chemokine receptor binding GO:0031731 8.62 DEFB1 DEFB4A

Sources for Oral Candidiasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....